In addition, inflammatory mediators such as C-reactive protein and interleukin-6 may contribute to the obesity-related bladder cancer risk as suggested by positive relation of circulating levels of inflammatory markers to bladder cancer mortality [27, 28]. The gene discussed is IL6; the disease is obesity disorder.